O35 Detection of circulating HLA-E in cancer patients: Potential application in cancer immunotherapy
Kanangat, V., Auger, C., Tarhoni, I., Borgia, J., Marshalla, M., DeCresce, R.
Published in Human immunology (01.09.2023)
Published in Human immunology (01.09.2023)
Get full text
Journal Article
PD01.03 Changes in Immune Checkpoints Landscape Associated with TGF-β Induced EMT in Lung Adenocarcinoma
Tarhoni, I., Moudgalya, H., Gerard, D., Borgia, J.
Published in Journal of thoracic oncology (01.11.2019)
Published in Journal of thoracic oncology (01.11.2019)
Get full text
Journal Article
Novel Autoantibodies Biomarkers Panel to Prognosticate the Clinical Outcomes in Advanced-stage NSCLC Patients Receiving Anti PD-1/PD-L1 Immunotherapy
Tarhoni, I, Fhied, C, Borgia, J A, Fidler, M J, Batus, M, Bonomi, P
Published in American journal of clinical pathology (28.10.2020)
Published in American journal of clinical pathology (28.10.2020)
Get full text
Journal Article
P76.30 The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in Patients with EGFR Mutated Advanced NSCLC
Rouhani, S., Yun, N., Bestvina, C., Gilmore, B., Ritz, E., Tarhoni, I., Batus, M., Borgia, J., Bonomi, P., Fidler, M.J.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
OA03.01 Biomarkers of Autoimmune Toxicity in Metastatic SCLC Patients Receiving PD-1/PDL-1 Targeted Therapy
Tarhoni, I., Tangri, A., Gilmore, B., Fidler, M., Batus, M., Bonomi, P., Borgia, J.
Published in Journal of thoracic oncology (01.11.2019)
Published in Journal of thoracic oncology (01.11.2019)
Get full text
Journal Article
P1.05 Clinical Factors Associated with Progression in Previously Treated Patients with Metastatic NSCLC on ANTI-PD-1 Therapy
Randall, M., Kollipara, R., Basu, S., Borgia, J., Batus, M., Bonomi, P., Tarhoni, I., Fughhi, I., Fidler, M.
Published in Journal of thoracic oncology (01.11.2019)
Published in Journal of thoracic oncology (01.11.2019)
Get full text
Journal Article
OA01.02 Prognostic Value of Baseline Autoantibodies in Metastatic NSCLC Patients Receiving PD-/PDL-1 Targeted Immunotherapy
Tarhoni, I., Kollipara, R., Li, W.-R., Moudgalya, H., Fidler, M., Batus, M., Bonomi, P., Borgia, J.
Published in Journal of thoracic oncology (01.11.2019)
Published in Journal of thoracic oncology (01.11.2019)
Get full text
Journal Article
Biomarkers of Autoimmune Toxicity in Metastatic SCLC Patients Receiving PD-1/PDL-1 Targeted Therapy: OA03.01
Tarhoni, I, Tangri, A, Gilmore, B, Fidler, M, Batus, M, Bonomi, P, Borgia, J
Published in Journal of thoracic oncology (01.11.2019)
Published in Journal of thoracic oncology (01.11.2019)
Get full text
Journal Article
Prognostic Value of Baseline Autoantibodies in Metastatic NSCLC Patients Receiving PD-/PDL-1 Targeted Immunotherapy: OA01.02
Tarhoni, I, Kollipara, R, Li, W.-R, Moudgalya, H, Fidler, M, Batus, M, Bonomi, P, Borgia, J
Published in Journal of thoracic oncology (01.11.2019)
Published in Journal of thoracic oncology (01.11.2019)
Get full text
Journal Article